121 related articles for article (PubMed ID: 9589361)
1. Colon cancer chemoprevention: clinical development of aspirin as a chemopreventive agent.
Krishnan K; Ruffin MT; Brenner DE
J Cell Biochem Suppl; 1997; 28-29():148-58. PubMed ID: 9589361
[TBL] [Abstract][Full Text] [Related]
2. Effect of aspirin on prostaglandin E2 formation and transforming growth factor alpha expression in human rectal mucosa from individuals with a history of adenomatous polyps of the colon.
Barnes CJ; Hamby-Mason RL; Hardman WE; Cameron IL; Speeg KV; Lee M
Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 1):311-5. PubMed ID: 10207634
[TBL] [Abstract][Full Text] [Related]
3. Colonic mucosal prostaglandin E2 and cyclooxygenase expression before and after low aspirin doses in subjects at high risk or at normal risk for colorectal cancer.
Krishnan K; Ruffin MT; Normolle D; Shureiqi I; Burney K; Bailey J; Peters-Golden M; Rock CL; Boland CR; Brenner DE
Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):447-53. PubMed ID: 11352853
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
5. Use of NSAIDs for the chemoprevention of colorectal cancer.
Herendeen JM; Lindley C
Ann Pharmacother; 2003 Nov; 37(11):1664-74. PubMed ID: 14565811
[TBL] [Abstract][Full Text] [Related]
6. Summary of recommendations for colonic biomarker studies of candidate chemopreventive compounds in phase II clinical trials.
Lipkin M
J Cell Biochem Suppl; 1994; 19():94-8. PubMed ID: 7823612
[TBL] [Abstract][Full Text] [Related]
7. Colorectal cancer prevention: is an ounce of prevention worth a pound of cure?
Gill S; Sinicrope FA
Semin Oncol; 2005 Feb; 32(1):24-34. PubMed ID: 15726503
[TBL] [Abstract][Full Text] [Related]
8. Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis.
Reddy BS; Hirose Y; Lubet R; Steele V; Kelloff G; Paulson S; Seibert K; Rao CV
Cancer Res; 2000 Jan; 60(2):293-7. PubMed ID: 10667579
[TBL] [Abstract][Full Text] [Related]
9. Novel approaches for colon cancer prevention by cyclooxygenase-2 inhibitors.
Reddy BS; Rao CV
J Environ Pathol Toxicol Oncol; 2002; 21(2):155-64. PubMed ID: 12086402
[TBL] [Abstract][Full Text] [Related]
10. Effects of piroxicam on prostaglandin E2 levels in rectal mucosa of adenomatous polyp patients: a randomized phase IIb trial.
Calaluce R; Earnest DL; Heddens D; Einspahr JG; Roe D; Bogert CL; Marshall JR; Alberts DS
Cancer Epidemiol Biomarkers Prev; 2000 Dec; 9(12):1287-92. PubMed ID: 11142413
[TBL] [Abstract][Full Text] [Related]
11. Use and safety of aspirin in the chemoprevention of colorectal cancer.
Singh AK; Trotman BW
J Assoc Acad Minor Phys; 1998; 9(2):40-4. PubMed ID: 9648425
[TBL] [Abstract][Full Text] [Related]
12. Studies with the azoxymethane-rat preclinical model for assessing colon tumor development and chemoprevention.
Reddy BS
Environ Mol Mutagen; 2004; 44(1):26-35. PubMed ID: 15199544
[TBL] [Abstract][Full Text] [Related]
13. Effects of low dose aspirin (81 mg) on proliferating cell nuclear antigen and Amaranthus caudatus labeling in normal-risk and high-risk human subjects for colorectal cancer.
Krishnan K; Aoki T; Ruffin MT; Normolle DP; Boland CR; Brenner DE
Cancer Detect Prev; 2004; 28(2):107-13. PubMed ID: 15068834
[TBL] [Abstract][Full Text] [Related]
14. Modulation of DNA hypomethylation as a surrogate endpoint biomarker for chemoprevention of colon cancer.
Tao L; Wang W; Kramer PM; Lubet RA; Steele VE; Pereira MA
Mol Carcinog; 2004 Feb; 39(2):79-84. PubMed ID: 14750212
[TBL] [Abstract][Full Text] [Related]
15. Development of difluoromethylornithine (DFMO) as a chemoprevention agent.
Meyskens FL; Gerner EW
Clin Cancer Res; 1999 May; 5(5):945-51. PubMed ID: 10353725
[TBL] [Abstract][Full Text] [Related]
16. Non-steroidal anti-inflammatory drugs and selective apoptotic anti-neoplastic drugs in the prevention of colorectal cancer: the role of super aspirins.
Strul H; Arber N
Isr Med Assoc J; 2000 Sep; 2(9):695-702. PubMed ID: 11062772
[TBL] [Abstract][Full Text] [Related]
17. Chemoprevention of colorectal cancer.
Das D; Arber N; Jankowski JA
Digestion; 2007; 76(1):51-67. PubMed ID: 17947819
[TBL] [Abstract][Full Text] [Related]
18. Effect of aspirin on prostaglandin E2 and leukotriene B4 production in human colonic mucosa from cancer patients.
Frommel TO; Dyavanapalli M; Oldham T; Kazi N; Lietz H; Liao Y; Mobarhan S
Clin Cancer Res; 1997 Feb; 3(2):209-13. PubMed ID: 9815674
[TBL] [Abstract][Full Text] [Related]
19. Colorectal cancer--chemoprevention.
Boone WT
J Miss State Med Assoc; 1998 Sep; 39(9):318-22. PubMed ID: 9757628
[TBL] [Abstract][Full Text] [Related]
20. The prevention of colorectal cancer by aspirin use.
Giovannucci E
Biomed Pharmacother; 1999 Aug; 53(7):303-8. PubMed ID: 10472428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
